Why the study?
Does fenoldopam effectively control mean arterial pressure in children with hypertensive emergencies or requiring controlled hypotension?
Does fenoldopam effectively control mean arterial pressure in children with hypertensive emergencies or requiring controlled hypotension?
Answers are grounded in this paper and cite their sources.
This case series provides preliminary clinical experience supporting the potential use of fenoldopam for blood pressure control in pediatric patients.
Fenoldopam is a direct-acting vasodilator that acts at the postsynaptic dopamine 1 receptors in renal, coronary, cerebral, and splanchnic vasculature resulting in arterial dilation and a lowering of the mean arterial pressure (MAP). Preliminary evidence suggests its efficacy in the treatment of hypertensive urgencies and emergencies in adults. We present four children in whom fenoldopam was used to control MAP in various clinical scenarios, including hypertensive emergencies and urgencies, intraoperative reduction of MAP for controlled hypotension, and control of MAP during extracorporeal membrane oxygenation. The possible applications of fenoldopam and suggested dosing regimens in children are reviewed.
No takes yet. Share an insight, caveat, or question.
Strauser et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: